Streetbeat News

Regulatory

EIS

SPY

USO

VGK

The White House has reported that 27 Americans have died following a Hamas attack, with 14 still unaccounted for. Starting Friday, the U.S. government will arrange charter flights from Israel to Europe.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 5:16 pm

AVGO

VMW

Broadcom's (AVGO) acquisition of VMware (VMW) is expected to receive conditional antitrust approval from China's State Administration for Market Regulation. The $60 billion deal is likely to boost Broadcom's shares significantly, according to CNBC's Jim Cramer. Both Broadcom and VMware saw their shares rise by 3% and 4% respectively on the news.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 5:04 pm

BABA

KWEB

Alibaba Group Holding Limited (BABA) and KraneShares Trust KraneShares CSI China Internet ETF (KWEB) stocks are trading lower amid reports of China's President Xi Jinping calling for accelerated efforts in core technologies. The U.S. plans to increase semiconductor tech sanctions on China, which could impact China's tech industry. China is planning a $40 billion state fund to boost the chip industry.

Portfolio Pulse from Anusuya Lahiri

October 12, 2023 | 4:58 pm

BON

Bon Natural Life Ltd has regained compliance with Nasdaq's Listing Rule 5605, as per the notification received from Nasdaq on October 9.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:57 pm

SPY

USO

U.S. Secretary of State, Blinken, has stated that none of the $6 billion Iran fund has been accessed.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:42 pm

DXCM

Shares of DexCom, Inc. (NASDAQ:DXCM) are trading lower after the FDA announced the establishment of a Digital Health Advisory Committee. The committee, which aims to be fully operational by 2024, will focus on addressing the complexities of digital health technologies. This increased regulatory interest introduces uncertainty for companies like DexCom, potentially impacting their products, market access, and ability to innovate.

Portfolio Pulse from Henry Khederian

October 12, 2023 | 4:35 pm

PMVP

PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) has announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE clinical trial. The trial showed that PC14586 achieved efficacy in heavily pretreated patients across multiple tumor types and was well tolerated with a favorable safety profile. The company plans to initiate a registrational Phase 2 trial in early 2024.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:32 pm

EIS

SPY

U.S. Secretary of State Blinken is set to meet with the Jordanian King and Palestinian Authority President Abbas. He has stated that the U.S. will seek the immediate, unconditional release of hostages.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:28 pm

EIS

SPY

U.S. Secretary of State, Blinken, has met with families of Americans who were killed or taken hostage by Hamas in Israel. The U.S. is doing everything it can to secure the release of the hostages.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:26 pm

BTI

British American Tobacco (BAT) has expressed disappointment at the FDA's Marketing Denial Orders (MDOs) for Vuse Alto's Menthol and Mixed Berry products. The company plans to challenge the decision and seek a stay of enforcement. The FDA's decision was based on the absence of long-term consumer switching data for these products. BAT argues that this decision contradicts proven science and the FDA's goal of reducing the health effects of tobacco use. The company also expressed concern about the FDA allowing the proliferation of youth-appealing vapor products.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:23 pm